Furthermore, the number of B regulatory (Bregs) cells with CD19+CD24highCD38high phenotype, increases in the transition from MGUS to symptomatic MM [65], supporting the bone marrow milieu by both reducing NK-mediated lysis of MM cells and producing IL-10 [66]. Here, CD19 is linked to Miyoshi myopathy.